I+D de fármacos
GI-1606
![Foto de I+D de fármacos](/img/grupo.png)
![Foto de Universidad Andrés Bello](/img/noimage_org.png)
Universidad Andrés Bello
Santiago de Chile, ChilePublicacións en colaboración con investigadores/as de Universidad Andrés Bello (5)
2022
-
Synthesis and study of the trypanocidal activity of catechol-containing 3-arylcoumarins, inclusion in β-cyclodextrin complexes and combination with benznidazole
Arabian Journal of Chemistry, Vol. 15, Núm. 3
2021
-
New benzimidazolequinones as trypanosomicidal agents
Bioorganic Chemistry, Vol. 111
-
Theobroma cacao L. compounds: Theoretical study and molecular modeling as inhibitors of main SARS-CoV-2 protease
Biomedicine and Pharmacotherapy, Vol. 140
2020
-
In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease
Frontiers in Chemistry, Vol. 8
2019
-
Novel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease
ChemistrySelect, Vol. 4, Núm. 2, pp. 551-558